Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Jun;7(2):118-127.
doi: 10.15420/aer.2018.18.2.

Risk Factor Management in Atrial Fibrillation

Axel Brandes  1 , Marcelle D Smit  2 , Bao Oanh Nguyen  2 , Michiel Rienstra  2 , Isabelle C Van Gelder  1   2
Affiliations
Review

Risk Factor Management in Atrial Fibrillation

Axel Brandes et al. Arrhythm Electrophysiol Rev. 2018 Jun.

Abstract

Atrial fibrillation (AF) is the most common clinical arrhythmia and is associated with increased morbidity and mortality. There is growing evidence that numerous cardiovascular diseases and risk factors are associated with incident AF and that lone AF is rare. Beyond oral anticoagulant therapy, rate and rhythm control, therapy targeting risk factors and underlying conditions is an emerging AF management strategy that warrants better implementation in clinical practice. This review describes current evidence regarding the association between known modifiable risk factors and underlying conditions and the development and progression of AF. It discusses evidence for the early management of underlying conditions to improve AF outcomes. It also provides perspective on the implementation of tailored AF management in daily clinical practice.

Keywords: Atrial fibrillation; integrated management; lifestyle modification; prevention; risk factors.

PubMed Disclaimer

Conflict of interest statement

Disclosure: The authors have no conflicts of interest to declare.

Figures

Figure 1:
Figure 1:. Risk Factors and Underlying Comorbidities to be Addressed in Chronic Comprehensive Atrial Fibrillation Management
Figure 2:
Figure 2:. Time-dependent Atrial Remodelling and Development of Atrial Fibrillation
See this image and copyright information in PMC

References

    1. Chugh SS, Havmoeller R, Narayanan K et al. Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study. Circulation. 2014;129:837–47. doi: 10.1161/CIRCULATIONAHA.113.005119. - DOI - PMC - PubMed
    1. Colilla S, Crow A, Petkun W et al. Estimates of current and future incidence and prevalence of atrial fibrillation in the U.S. adult population. Am J Cardiol. 2013;112:1142–7. doi: 10.1016/j.amjcard.2013.05.063. - DOI - PubMed
    1. Bjorck S, Palaszewski B, Friberg L, Bergfeldt L. Atrial fibrillation, stroke risk, and warfarin therapy revisited: a population-based study. Stroke. 2013;44:3103–8. doi: 10.1161/STROKEAHA.113.002329. - DOI - PubMed
    1. Haim M, Hoshen M, Reges O et al. Prospective national study of the prevalence, incidence, management and outcome of a large contemporary cohort of patients with incident non-valvular atrial fibrillation. J Am Heart Assoc. 2015;4:e001486. doi: 10.1161/JAHA.114.001486. - DOI - PMC - PubMed
    1. Krijthe BP, Kunst A, Benjamin EJ et al. Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060. Eur Heart J. 2013;34:2746–51. doi: 10.1093/eurheartj/eht280. - DOI - PMC - PubMed

LinkOut - more resources